Anti-Human CD20 Recombinant Antibody(Ocrelizumab)
- 
									
产品编号
YR1145
 - 
									
别名
科研级 Ocrelizumab ( 奥瑞组单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocrelizumab
 - 
									
规格
- 1mg
 - 5mg
 
 
| Catalog Number | YR1145 | 
| Alias | 科研级 Ocrelizumab ( 奥瑞组单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocrelizumab | 
| Size | 1mg, 5mg | 
| Molecular Name | Ocrelizumab | 
| CAS Number | 637334-45-3 | 
| Molecular Weight | 145 kDa | 
| Target | CD20[Homo sapiens] | 
| Antibody Isotype | IgG1 | 
| Clonity | Monoclonal | 
| Concentration | 1mg/ml | 
| Purity | >95% as determined by SDS-PAGE | 
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, pH7.5 | 
| Shipping Condition | Shipped on ice packs. | 
| Background | Ocrelizumab, sold under the brand name Ocrevus, is a pharmaceutical drug for the treatment of multiple sclerosis (MS). It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug. | 
| Application | ELISA, IP, FCM, FuncS, Neut, IF | 
| Remarks | This product is for research use only. | 
							
							
							
							
						
								0